Advertisement
-
1
Walsh SM, Fischer SG, Sage RA: Survival of patients with primary pedal melanoma. J Foot Ankle Surg 42: 193, 2003.
-
2
Anbari KK, Schuchter LM, Bucky LP, et al: Melanoma of unknown primary site. Cancer 79: 1816, 1997.
-
3
Schlagenhauff B, Stroebel W, Ellwanger U, et al: Metastatic melanoma of unknown primary origin shows prognostic similarities to regional metastatic melanoma. Cancer 80: 60, 1997.
-
4
Bae JM, Choi YY, Kim DS, et al: Metastatic melanomas of unknown primary show a better prognosis than those of known primary: a systematic review and meta-analysis of observational studies. J Am Acad Dermatol 72: 59, 2015
-
5
Greene FL, Trotti A, Fritz AG, et al, eds. AJCC Cancer Staging Handbook, 7th Ed, American Joint Committee on Cancer, Chicago, 2010.
-
6
Barnes BC, Seigler HF, Saxby TS, et al: Melanoma of the foot. J Bone Joint Surg Am 76: 892, 1994.
-
7
Day CL, Sober AJ, Kopf AW, et al: A prognostic model for clinical stage I melanoma of the lower extremity: location on foot as independent risk factor for recurrent disease. Surgery 89: 599, 1981.
-
8
Fortin PT, Freiberg AA, Rees R, et al: Malignant melanoma of the foot and ankle. J Bone Joint Surg Am 77: 1396, 1995.
-
9
Garbe C, Buttner P, Bertz J, et al: Primary cutaneous melanoma: prognostic classification of anatomic location. Cancer 75: 2492, 1995.
-
10
Wong JH, Cagle LA, Morton DL: Surgical treatment of lymph nodes with metastatic melanoma from unknown primary site. Arch Surg 122: 1380, 1987.
-
11
Van der Ploeg PA, Haydu LE, Spillane AJ, et al: Melanoma patients with an unknown primary tumor site have a better outcome than those with a known primary following therapeutic lymph node dissection for macroscopic (clinically palpable) nodal disease. Ann Surg Oncol 21: 3108, 2014.
-
12
Lee C, Faries M, Wanek L, et al: Improved survival for stage IV melanoma from an unknown primary site. J Clin Oncol 27: 3489, 2009.
-
13
Weide B, Faller C, Elsasser M, et al: Melanoma patients with unknown primary site or nodal recurrence after initial diagnosis have a favourable survival compared to those with synchronous lymph node metastasis and primary tumour. PLoS One 8: e66953, 2013.
-
14
Van Beek E, Balm A, Nieweg O, et al: Treatment of regional metastatic melanoma of unknown primary origin. Cancers (Basel) 7: 1543, 2015.
-
15
Luke J, Ott P: PD-1 pathway inhibitors: the next generation of immunotherapy for advanced melanoma. Oncotarget 6: 3479, 2015.
-
16
Egberts F, Bergner I, Kruger S, et al: Metastatic melanoma of unknown primary resembles the genotype of cutaneous melanomas. Ann Oncol 25: 246, 2014.
Metastatic Melanoma of a Metatarsal
A Case Report
Search for other papers by Gary Friend in
Current site
Google Scholar
PubMed
Search for other papers by Jeffrey Mitchell in
Current site
Google Scholar
PubMed
A 53-year-old woman presented with painful swelling of the right forefoot presenting clinically as a metatarsal stress fracture. Radiographs showed destructive changes, and diagnostic imaging revealed an aggressive neoplasm. The lesion was biopsied, and the pathologic diagnosis was metastatic melanoma. A thorough physical examination and advanced imaging did not reveal a primary tumor. Ray resection was performed with en bloc resection of the neoplasm. The patient continues to receive long-term immune stimulation chemotherapy 34 months after the ray resection.
